Skip to main content

Our Partners

Sponsors

OBRI receives unrestricted grants from pharmaceutical industry partners who support our research mission while upholding scientific independence.

Current Sponsors (2026/2027)

Gold Partners
Celltrion
Celltrion
Janssen
Janssen
Silver Partners
Pfizer
Pfizer
Bronze Partners
AbbVie
AbbVie
Amgen
Amgen
Organon
Organon
Sanofi
Sanofi
UCB
UCB

Interested in supporting OBRI? Contact us at Angela.Cesta@uhn.ca to learn about partnership opportunities.

Industry Sponsorship Program

OBRI offers structured partnership tiers for industry sponsors, providing meaningful scientific engagement while maintaining full research independence.

WHY OBRI? Real patients. Real-world care. Canadian evidence.

BenefitGoldSilverBronze
Annual contribution$75,000+$50,000+$25,000+
Core registry operations and data quality
Analyst and research capacityDedicated / priorityPartial / sharedProject-specific
Scientific exchange with OBRI leadershipAnnual 60-minute meetingAnnual research updateAnnual written summary
Prioritized feasibility or aggregate analyses1–2 annually1 annually
Research portfolio and publication updates
Invitation to OBRI Annual Research Day
Recognition on OBRI website and annual materialsGold-level partnerSilver-level partnerBronze-level partner
Acknowledgement in supported abstracts, posters, presentations and manuscripts
Opportunity to propose research questions
Educational and knowledge-translation activitiesPriority opportunityParticipation opportunityAcknowledgement
Exclusive partnership within a defined OBRI program of research

Past Sponsors

OBRI is grateful to the following organizations for their past support through unrestricted grants.

AuroraBioconBristol-Myers SquibbCelgeneFresenius KabiGileadHospiraLillyMedexusMerckNovartisRocheSandoz